Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)

HLA-G is a nonclassical MHC class I (MHCI) molecule that can suppress a wide range of immune responses in the maternal–fetal interface. The human inhibitory immune receptors leukocyte Ig-like receptor (LILR) B1 [also called LIR1, Ig-like transcript 2 (ILT2), or CD85j] and LILRB2 (LIR2/ILT4/CD85d) preferentially recognize HLA-G. HLA-G inherently exhibits various forms, including β2-microglobulin (β2m)-free and disulfide-linked dimer forms. Notably, LILRB1 cannot recognize the β2m-free form of HLA-G or HLA-B27, but LILRB2 can recognize the β2m-free form of HLA-B27. To date, the structural basis for HLA-G/LILR recognition remains to be examined. Here, we report the 2.5-Å resolution crystal structure of the LILRB2/HLA-G complex. LILRB2 exhibits an overlapping but distinct MHCI recognition mode compared with LILRB1 and dominantly recognizes the hydrophobic site of the HLA-G α3 domain. NMR binding studies also confirmed these LILR recognition differences on both conformed (heavy chain/peptide/β2m) and free forms of β2m. Binding studies using β2m-free MHCIs revealed differential β2m-dependent LILR-binding specificities. These results suggest that subtle structural differences between LILRB family members cause the distinct binding specificities to various forms of HLA-G and other MHCIs, which may in turn regulate immune suppression.

[1]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[2]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[3]  P. Bjorkman,et al.  Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor , 2003, Nature Immunology.

[4]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[5]  Hiroshi Hashimoto,et al.  Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. , 2005, Human molecular genetics.

[6]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[7]  A. McMichael,et al.  HLA-B27 Heavy Chain Homodimers Are Expressed in HLA-B27 Transgenic Rodent Models of Spondyloarthritis and Are Ligands for Paired Ig-Like Receptors1 , 2004, The Journal of Immunology.

[8]  D. Cosman,et al.  The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium. , 2002, The American journal of pathology.

[9]  A. West,et al.  Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). , 2000, Immunity.

[10]  Kouhei Tsumoto,et al.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Bowness.  HLA B27 in health and disease: a double-edged sword? , 2002, Rheumatology.

[12]  D. Kohda,et al.  Crystal Structure of the Human Monocyte-activating Receptor, “Group 2” Leukocyte Ig-like Receptor A5 (LILRA5/LIR9/ILT11)* , 2006, Journal of Biological Chemistry.

[13]  A. West,et al.  Crystal structure of LIR-2 (ILT4) at 1.8 Å: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18 , 2002, BMC Structural Biology.

[14]  M. Colonna,et al.  Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4 , 2002, Nature Immunology.

[15]  A. McMichael,et al.  Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells , 1999, The Journal of experimental medicine.

[16]  J. Hanna,et al.  Complexes of HLA-G Protein on the Cell Surface Are Important for Leukocyte Ig-Like Receptor-1 Function1 , 2003, The Journal of Immunology.

[17]  J. Strominger,et al.  Disulfide bond-mediated dimerization of HLA-G on the cell surface , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. McMichael,et al.  Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. , 1999, Journal of immunology.

[19]  C. Ober,et al.  HLA‐G and immune tolerance in pregnancy , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  A. Nakamura,et al.  Exacerbated graft-versus-host disease in Pirb−/− mice , 2004, Nature Immunology.

[21]  Michael J. Wilson,et al.  Cutting Edge: Leukocyte Receptor Complex-Encoded Immunomodulatory Receptors Show Differing Specificity for Alternative HLA-B27 Structures1 , 2001, The Journal of Immunology.

[22]  J. McCluskey,et al.  Biology and functions of human leukocyte antigen-G in health and sickness. , 2003, Tissue antigens.

[23]  P. Bjorkman,et al.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.

[24]  B C Finzel,et al.  Three-dimensional structure of an antibody-antigen complex. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Trowsdale,et al.  The LILR family: modulators of innate and adaptive immune pathways in health and disease. , 2004, Tissue antigens.

[26]  Manfred Brockhaus,et al.  A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing , 1997, The Journal of experimental medicine.

[27]  J. McCluskey,et al.  Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Kubin,et al.  A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. , 1997, Journal of immunology.

[29]  Y. Shirakihara,et al.  Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j). , 2006, Journal of molecular biology.

[30]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[31]  Kouhei Tsumoto,et al.  Efficient Leukocyte Ig-like Receptor Signaling and Crystal Structure of Disulfide-linked HLA-G Dimer* , 2006, Journal of Biological Chemistry.

[32]  G. Ogg,et al.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. , 1998, Journal of immunology.

[33]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[34]  H. Achdout,et al.  The CD85J/Leukocyte Inhibitory Receptor-1 Distinguishes between Conformed and β2-Microglobulin-Free HLA-G Molecules1 , 2005, The Journal of Immunology.